Owner Expression Diagnostics, Inc.

Inventors Wohlgemuth, Jay; Morris, MacDonald; Rosenberg, Steven; Ly, Ngoc; Fry, Kirk; Prentice, James; Woodward, Robert

Agent Davies Collison Cave

Pub. Number AU-B-2003299465

PCT Number PCT/US2003/0129

PCT Pub. Number WO2004/042346

Priority 10/131,831 24.04.02 US; 10/325,899 20.12.02 US

Filing date 24 April 2003

Wipo publication date 7 June 2004

Acceptance publication date 15 February 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 1/00 (2006.01) Sampling

G01N 24/08 (2006.01) Investigating or analysing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent